Yingli Ma serves as Executive at Structure Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Yingli Ma has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 1, 2025 involved receiving (via award) 24,459 shares valued at $0.
Yingli Ma currently holds 123,174 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yingli Ma has been a net neutral trader of GPCR stock. They have purchased $0 and sold $0 worth of shares.
Yingli Ma's most recent insider trade was on Jul 1, 2025, when they sold 24,459 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.84 |
| Discretionary |
| Mar 1, 2025 | GPCR | $14.4K | Payment | 1,824 | $7.92 | Discretionary |
| Mar 15, 2024 | GPCR | $0 | Award | 36,729 | $N/A | Discretionary |